Stock_Titan
Posted - 14 hours ago
$NBTX Voting Rights and Shares Capital of the Company
https://www.stocktitan.net/news/NBTX/voting-rights-and-shares-capital-of-the-upzyahc2amnv.html
Stock_Titan
Posted - 1 day ago
$NBTX NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
https://www.stocktitan.net/news/NBTX/nanobiotix-to-announce-first-quarter-operational-and-financial-48rjw3mdoa85.html
DonCorleone77
Posted - 2 days ago
$NBTX $JNJ Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study Nanobiotix (NBTX) announced that the FDA issued a Study May Proceed Letter for a randomized Phase 2 study evaluating NBTXR3 for the treatment of patients with stage 3, unresectable non-small cell lung cancer. An IND to support this trial was submitted by the global trial sponsor, Johnson & Johnson Enterprise Innovation Inc., a Johnson & Johnson (JNJ) company.
Stock_Titan
Posted - 2 days ago
$NBTX NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
https://www.stocktitan.net/news/NBTX/nanobiotix-announces-us-fda-protocol-acceptance-for-new-randomized-crq7rw46sz85.html
Stock_Titan
Posted - 04/24/24
$NBTX NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
https://www.stocktitan.net/news/NBTX/nanobiotix-provides-business-update-and-reports-full-year-2023-q21g25mbr5yj.html
Stock_Titan
Posted - 4 weeks ago
$NBTX NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
https://www.stocktitan.net/news/NBTX/nanobiotix-to-announce-fourth-quarter-and-full-year-2023-operational-98qob21jbfaa.html
Stock_Titan
Posted - 1 month ago
$NBTX Voting Rights and Shares Capital of the Company
https://www.stocktitan.net/news/NBTX/voting-rights-and-shares-capital-of-the-s8mf0fkt0sl9.html
AlertsAndNews
Posted - 1 month ago
Updated Gappers in after hours trading $MRIN $INAB $JAGX $JZXN $NBTX Enjoy your evening, see you in the AM for CPI!
Monster_Mover_Stocks
Posted - 1 month ago
$NBTX End of after-hours low float sub $10 volume buzz leader occurring late in the day with several daily chart indicator highs. Ending after-hours price is $6.38. Watchlist worthy.
Monster_Mover_Stocks
Posted - 1 month ago
$NBTX Current sub $10 low float after-hours volume buzz leader. Current price is $6.45.
DonCorleone77
Posted - 1 month ago
$NBTX 2 of 2 - Nanobiotix completes dose escalation of of radioenhancer NBTXR3 study ....While these patients experience different cancer types and are each faced with unique challenges, what they share is an urgent need for therapeutic innovation with the chance to make a difference," said Louis Kayitalire, MD, Chief Medical Officer at Nanobiotix. "We believe the injection feasibility and favorable safety profile we have observed from the completed dose escalation part of this Phase 1 lung cancer study could pave the way for additional clinical development of NBTXR3 for patients with inoperable, recurrent lung cancer and patients amenable to re-irradiation."
DonCorleone77
Posted - 1 month ago
$NBTX 1 of 2 - Nanobiotix completes dose escalation of of radioenhancer NBTXR3 study Nanobiotix announced completion of the dose escalation part of a Phase 1 study evaluating potential first-in-class radioenhancer NBTXR3 for patients with non-small cell lung cancer that cannot be treated by surgery inoperable , and has come back or recurrent, whom have previously been treated with definitive radiation therapy and are amenable to re-irradiation. The Phase 1 study is being conducted by The University of Texas MD Anderson Cancer Center as part of an ongoing strategic collaboration with Nanobiotix. "NBTXR3 is designed as a product candidate with the potential to improve treatment outcomes for patients with cancer in any setting where radiotherapy is a part of the treatment regimen....
Stock_Titan
Posted - 1 month ago
$NBTX Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
https://www.stocktitan.net/news/NBTX/nanobiotix-announces-completion-of-phase-1-dose-escalation-and-sw2bw81shco9.html
joka2189
Posted - 03/19/24
$PNT $RYZB $PSTV $FUSN $NBTX another one bites the dust. Bye Fusion👋
Stock_Titan
Posted - 2 months ago
$NBTX Nanobiotix to Present at Upcoming Investor Conferences in March
https://www.stocktitan.net/news/NBTX/nanobiotix-to-present-at-upcoming-investor-conferences-in-a4fhvpfl4x9j.html
Stock_Titan
Posted - 3 months ago
$NBTX Voting Rights and Shares Capital of the Company
https://www.stocktitan.net/news/NBTX/voting-rights-and-shares-capital-of-the-03ktpjn7mxgh.html
HellC
Posted - 3 months ago
$NBTX I'd say short till 3.50
momeymaker1
Posted - 01/30/24
$NBTX interesting can't stop trading itrm. Will be watching
OpenOutcrier
Posted - 01/30/24
$NBTX (+8.1% pre) Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study https://ooc.bz/l/23492
DonCorleone77
Posted - 01/29/24
$NBTX $JNJ Nanobiotixachieves $20M milestone payment from Johnson & Johnson subsidiary Nanobiotix announced achievement of operational requirements in NANORAY-312, an ongoing pivotal Phase 3 study evaluating potential first-in-class radioenhancer NBTXR3 for elderly patients with head and neck cancer, resulting in a $20M milestone payment from strategic partner Janssen Pharmaceutica, a Johnson & Johnson (JNJ) company. This $20M represents the first applicable development milestone from the global licensing agreement executed between Nanobiotix and Janssen.
tickeron
Posted - 01/20/24
How does this affect your portfolio? $NBTX entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4974103
Stock_Titan
Posted - 4 months ago
$NBTX Voting Rights and Shares Capital of the Company
https://www.stocktitan.net/news/NBTX/voting-rights-and-shares-capital-of-the-xhupqse6939h.html
joka2189
Posted - 4 months ago
$PNT $RYZB very hot space surprise surprise as another one for solids gets absorbed. Not too many go-it alones left in the 'race'! Big $PSTV Plus Point! $FUSN or $NBTX likely next ones to go. Horses for courses.
RocknrollTrading
Posted - 12/29/23
$NBTX … so $RYZB acquired for $4B by $BMY … yummy as it gives a minimum value to $NBTX of $70 per share … X10 from current valuation.
Doozio
Posted - 12/28/23
$NBTX 🧠👀 TTWO chop chop huckleberries 🧠⏰
DonCorleone77
Posted - 12/26/23
$NBTX $LIAN $JNJ Nanobiotix says LianBio enters NBTXR3 development pact with Johnson & Johnson Nanobiotix (NBTX) announced that partner LianBio (LIAN) has entered into an agreement with Janssen Pharmaceutica, a Johnson & Johnson (JNJ) company, whereby LianBio has assigned to Janssen LianBio's exclusive rights to develop and commercialize radioenhancer NBTXR3 in China, South Korea, Singapore, and Thailand. This agreement consolidates global development and commercialization rights of NBTXR3 with Janssen; streamlines the global alliance for co-development and registration of the radioenhancer with Nanobiotix; and includes all previously agreed upon economic terms between Nanobiotix and LianBio, including the Nanobiotix entitlement to receive up to an aggregate $220M in potential contingent, development and commercialization milestone payments along with tiered, low double-digit royalties based on net sales of NBTXR3 in Asian territories....
Stock_Titan
Posted - 12/26/23
$NBTX Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets
https://www.stocktitan.net/news/NBTX/nanobiotix-partner-lian-bio-assigns-its-development-and-ddggtzc1zzaz.html
tickeron
Posted - 12/24/23
A.I.dvisor made a bullish call on $NBTX, netting in a 13.02% gain over 2 weeks https://srnk.us/go/4950480
MarketBeat
Posted - 5 months ago
Nanobiotix's outperform rating reiterated at Leerink Partnrs. www.marketbeat.com/stocks/NASDAQ/NBTX/price-target/ $NBTX
